Cullinan Oncology Inc — Quarterly Financial Statistics (NASDAQ:CGEM) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 34.14 M36.63 M43.16 M57.61 M36.88 M 174.27 M Cash from investing activities -19.88 M-15.96 M36.8 M53.4 M67.39 M 141.63 M Cash from financing activities 1.32 M1.58 M0373 K0 1.96 M Free cash flow 34.14 M36.63 M43.16 M57.61 M36.88 M 174.27 M

News

Cullinan Therapeutics: Thesis Strengthening For T-Cell Engager Specialist (NASDAQ:CGEM)

Cullinan Therapeutics, Inc. (CGEM) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

TheStreet Pro Analysts Say, “Big Tech Names are Anything But Cheap – Buy These 2 Stocks Instead” - TipRanks.com

Guggenheim initiates Cullinan Oncology stock with Buy rating, $30 target

Cullinan Therapeutics Stock: Cash-Rich Biotech With Multiple Value Drivers (NASDAQ:CGEM)

Are Medical Stocks Lagging AIM ImmunoTech (AIM) This Year?

Here's What Could Help Cullinan Therapeutics (CGEM) Maintain Its Recent Price Strength

Cullinan Therapeutics plans data readouts for key autoimmune programs

Cowen reiterates Buy rating on Cullinan Oncology stock after ASH data

Cullinan Therapeutics, Inc. (CGEM) Discusses Initial CLN-049 Results and Development Strategy for AML Applications Transcript

Netflix, Tesla among market cap stock movers on Monday

Cullinan Oncology stock soars after promising AML treatment results